Sergio Fernandéz‐Pello
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Surgery top 5%
- Oncology top 5%
- Cancer Research top 5%
- Co-authors
- Saeed DabestaniBörje LjungbergAlessandro VolpeLorenzo MarconiAxel BexThomas LamFabian HofmannMilan Hora
- Topics
- Renal cell carcinoma treatment (27 papers)Renal and related cancers (18 papers)Bladder and Urothelial Cancer Treatments (13 papers)
- Partner nations
- SpainUnited KingdomPortugal
In The Last Decade
Sergio Fernandéz‐Pello
44 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Pulmonary and Respiratory Medicine 2.4k
- Molecular Biology 1.4k
- Surgery 673
- Oncology 648
- Cancer Research 578
Countries citing papers authored by Sergio Fernandéz‐Pello
This map shows the geographic impact of Sergio Fernandéz‐Pello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Fernandéz‐Pello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Fernandéz‐Pello more than expected).
Fields of papers citing papers by Sergio Fernandéz‐Pello
This network shows the impact of papers produced by Sergio Fernandéz‐Pello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Fernandéz‐Pello. The network helps show where Sergio Fernandéz‐Pello may publish in the future.
Co-authorship network of co-authors of Sergio Fernandéz‐Pello
This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Fernandéz‐Pello. A scholar is included among the top collaborators of Sergio Fernandéz‐Pello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Fernandéz‐Pello. Sergio Fernandéz‐Pello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 29 | |
| 4 | 7 | |
| 5 | 32 | |
| 6 | 2 | |
| 7 | 49 | |
| 8 | 64 | |
| 9 | 8 | |
| 10 | European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Updatebreakdown → | 1000 |
| 11 | 65 | |
| 12 | 107 | |
| 13 | 69 | |
| 14 | 128 | |
| 15 | 2 | |
| 16 | 5 | |
| 17 | 12 | |
| 18 | 4 | |
| 19 | 3 | |
| 20 | 12 |
About Sergio Fernandéz‐Pello
Sergio Fernandéz‐Pello is a scholar working on Urology, Pulmonary and Respiratory Medicine and Surgery, having authored 50 papers that have together received 3.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (27 papers), Renal and related cancers (18 papers) and Bladder and Urothelial Cancer Treatments (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.4k citations), Cancer Research (578 citations) and Oncology (648 citations). Sergio Fernandéz‐Pello has collaborated with scholars based in Spain, United Kingdom and Portugal. Frequent co-authors include Saeed Dabestani, Börje Ljungberg, Alessandro Volpe, Lorenzo Marconi, Axel Bex, Thomas Lam, Fabian Hofmann, Milan Hora, Rana Tahbaz and Laurence Albigès. Their work appears in journals such as Journal of Clinical Oncology, European Urology and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.